RecruitingPhase 3NCT04804553
Rare condition
Psoriasis-related juvenile idiopathic arthritis
9
studies recruiting now
as of 7 Sept 2026
20
studies registered in total
as of 7 Sept 2026
30
countries with a recruiting site
as of 7 Sept 2026
27 Dec 2024
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 3NCT06100744
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
RecruitingPhase 3NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
RecruitingPhase 3NCT03773965
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
RecruitingPhase 1NCT06751238
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 9 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Psoriasis-related juvenile idiopathic arthritis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Psoriasis-related juvenile idiopathic arthritis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
2 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Deucravacitinib (Sotyktu)
Phase 3Secukinumab (Cosentyx)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).